Have a personal or library account? Click to login

References

  1. 1. Chen W, Plewig G. Human demodicosis: Revisit and a proposed classification. Br J Dermatol. 2014;170(6):1219-25.10.1111/bjd.12850
  2. 2. Powell F. Rosacea. In: Griffiths G, Barker J, Bleiker T, et. al., editors. Rook’s Textbook of Dermatology. Ninth. Chichester: John Wiley&Sons Ltd; 2016: 91.1-91.19.
  3. 3. Asai Y, Tan J, Baibergenova A, Barankin B, Cochrane CL, Humphrey S, et al. Canadian clinical practice guidelines for rosacea. J Cutan Med Surg 2016 Sep 1;20(5):432-45.10.1177/1203475416650427
  4. 4. Tan J, Berg M. Rosacea: Current state of epidemiology. J Am Acad Dermatol [Internet]. 2013;69(6 SUPPL.1):27-35.10.1016/j.jaad.2013.04.043
  5. 5. Chosidow O, Cribier B. Epidemiology of rosacea: Updated data. In: Ann Dermatol Venereol. Elsevier Masson; 2011:179-83.10.1016/S0151-9638(11)70087-4
  6. 6. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: Part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015 May 1;72(5):749-58.10.1016/j.jaad.2014.08.02825890455
  7. 7. Ozbagcivan O, Ozturk T, Akarsu S, Ilknur T, Fetil E. Evaluation of metabolic syndrome and its components in patients with rosacea: A cross-sectional, case-control study. Hong Kong J Dermatol. 2020;28(2):55-62.
  8. 8. Searle T, Al-Niaimi F, Ali FR. Rosacea and the cardiovascular system. Vol. 19, J Cosmet Dermatol. Blackwell Publishing Ltd; 2020:2182-7.10.1111/jocd.1358732621366
  9. 9. Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol. 2010;24(5):565-71.10.1111/j.1468-3083.2009.03472.x19874433
  10. 10. Chen Q, Shi X, Tang Y, Wang B, Xie H fu, Shi W, et al. Association between rosacea and cardiometabolic disease: A systematic review and meta-analysis. J Am Acad Dermatol. 2020 Nov 1;83(5):1331-40.10.1016/j.jaad.2020.04.11332360724
  11. 11. Forton FMN. Papulopustular rosacea, skin immunity and Demodex: Pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol. 2012;26(1):19-28.10.1111/j.1468-3083.2011.04310.x22017468
  12. 12. Forton FMN. The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea? Vol. 10, Dermatology and Therapy. Adis; 2020:1229-53.10.1007/s13555-020-00458-9764919033095403
  13. 13. Forton FMN. Elucidating the role of Demodex folliculorum in the pathogenesis of rosacea: exciting first steps…. Br J Dermatol. 2018;179(2):252-3.
  14. 14. Forton F, de Maertelaer V. Erythematotelangiectatic rosacea and subclinical demodicosis. Br J Dermatol. 2019;181(4):101-101.10.1111/bjd.18397
  15. 15. Forton FMN, de Maertelaer V. Rosacea and demodicosis: Little-known diagnostic signs and symptoms. Acta Derm Venereol. 2018;99(1):47-52.
  16. 16. Forton FMN, de Maertelaer V. Two consecutive standardized skin surface biopsies: An improved sampling method to evaluate demodex density as a diagnostic tool for rosacea and demodicosis. Acta Derm Venereol. 2017;97(2):242-8.10.2340/00015555-252827573185
  17. 17. Forton FMN, de Maertelaer V. Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms. J Eur Acad Dermatol Venereol. 2019; 34(2):365-9.
  18. 18. Forton FMN, de Maertelaer V. Papulopustular rosacea and rosacea-like demodicosis: two phenotypes of the same disease? J Eur Acad Dermatol Venereol. 2018 Jun 1;32(6):1011-6.10.1111/jdv.14885600180829478301
  19. 19. Forton F, Germaux MA, Brasseur T, de Liever A, Laporte M, Mathys C, et al. Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice. J J Am Acad Dermatol. 2005;52(1):74-87.10.1016/j.jaad.2004.05.03415627084
  20. 20. Tas Cengiz Z, Ozkol HU, Beyhan YE, Ozturk M, Yilmaz H. Evaluation of some chronical diseases in etiopathogenesis of demodicosis. Dermatologica Sin. 2017;35(4):173-6.10.1016/j.dsi.2017.04.006
  21. 21. Belli AA, Gok SO, Akbaba G, Etgu F, Dogan G. The relationship between rosacea and insulin resistance and metabolic syndrome. Eur J Dermatol. 2016;26(3):260-4.10.1684/ejd.2016.274827328660
  22. 22. Petersmann A, Müller-Wieland D, Müller UA, Landgraf R, Nauck M, Freckmann G, et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp. Clin. Endocrinol. Diabetes. 2019;127(Suppl 1):1-7.10.1055/a-1018-907831860923
  23. 23. Tucker LA. Limited Agreement between Classifications of Diabetes and Prediabetes Resulting from the OGTT, Hemoglobin A1c, and Fasting Glucose Tests in 7412 U.S. Adults. J Clin Med. 2020;9(7):1-18.10.3390/jcm9072207740866732668564
  24. 24. Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, et al. Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. Int J Endocrinol. 2020;2020:1-7.10.1155/2020/4678526708584532256572
  25. 25. Altemani A, Alamri A, Ahmed M, al Garbo M, Alharbi T, Al-Rasheed R, et al. Prediabetes and serum insulin levels. Int JComm Med Pub H. 2018;5(5):1684-9.10.18203/2394-6040.ijcmph20181494
  26. 26. Hay RJ. Demodex and skin disease - False creation or palpable form? Vol. 170, Br J Dermatol. Blackwell Publishing Ltd; 2014. p. 1214-5.10.1111/bjd.1301524947148
  27. 27. Lacey N, Ní Raghallaigh S, Powell FC. Demodex mites - Commensals, parasites or mutualistic organisms?, Dermatol. 2011;22(2): 128-30.10.1159/00032300921228556
  28. 28. Lacey N, Russell-Hallinan A, Powell FC. Study of Demodex mites: Challenges and Solutions. J Eur Acad Dermatol Venereol. 2016;30(5):764-75.10.1111/jdv.1351726695086
  29. 29. Friedman P, Cohen Sabban E, Cabo H. Usefulness of dermoscopy in the diagnosis and monitoring treatment of demodicidosis. Dermatol Pract Concept. 2017;7(1):35-8.10.5826/dpc.0701a06531503828243492
  30. 30. Hsu CK, Hsu MML, Lee JYY. Demodicosis: A clinicopathological study. J Am Acad Dermatol [Internet]. 2009;60(3):453-62.10.1016/j.jaad.2008.10.05819231642
  31. 31. García-Vargas A, Mayorga-Rodríguez JA, Sandoval-Tress C. Scalp demodicidosis mimicking favus in a 6-year-old boy. J Am Acad Dermatol. 2007;57(2):19-21.10.1016/j.jaad.2006.04.08217637363
  32. 32. Fernandez-Flores A, Alija A. Scalp folliculitis with Demodex: Innocent observer or pathogen? Vol. 13, Braz J Infect Dis. 2009. p. 81-2.10.1590/S1413-8670200900020000120140347
  33. 33. Sanfilippo AM, English JC. Resistant scalp folliculitis secondary to Demodex infestation. Cutis.2005;76:321-4.
  34. 34. Chuprov AD, Malgina EK. Modern aspects of etiopathogenetic treatment of ophthalmodemodicosis (literature review). Oftalmologiya.2018;15:281-5.10.18008/1816-5095-2018-2S-281-285
  35. 35. Huang Y, He H, Sheha H, Tseng SCG. Ocular demodicosis as a risk factor of pterygium recurrence. Ophthalmol. 2013;120(7):1341-7.10.1016/j.ophtha.2013.01.00123664471
  36. 36. Gao YY, Xu DL, Huang LJ, Wang R, Tseng SCG. Treatment of ocular itching associated with ocular demodicosis by 5% tea tree oil ointment. Cornea. 2012;31(1):14-7.10.1097/ICO.0b013e31820ce56c21955627
  37. 37. Cheng AMS, Sheha H, Tseng SCG. Recent advances on ocular Demodex infestation. Curr Opin Ophthalmol. 2015;26(4):295-300.10.1097/ICU.000000000000016826058028
  38. 38. Ewald B, Mrowietz U. Bilateral demodicosis of the nipple-areola complex. J Dtsch Dermatol Ges. 2019;17(7):733-4.10.1111/ddg.1384431012997
  39. 39. Douglas A, Zaenglein AL. A case series of demodicosis in children. Pediatr Dermatol. 2019;36(5):651-4.10.1111/pde.1385231197860
  40. 40. Álvarez-Salafranca M, Vicente A, Prat Torres C, Combalia A, Monsonís M, Celis-Passini VP, et al. Demodicosis in two patients with a previous history of Langerhans cell histiocytosis. Pediatr Dermatol. 2017;34(6):299-301.10.1111/pde.1328628940244
  41. 41. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal. 2017;38(32):2459-71.10.1093/eurheartj/ehx144583722528444290
  42. 42. Rainer BM, Kang S, Chien AL. Rosacea: Epidemiology, pathogenesis, and treatment. Derm.-Endocrinol. 2017;9(1):1938-72.
  43. 43. Li Y, Guo L, Hao D, Li X, Wang Y, Jiang X. Association between Rosacea and Cardiovascular Diseases and Related Risk Factors: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020;2020:1-11.10.1155/2020/7015249732028532685519
  44. 44. Katsambas A, Dessinioti C. The changing faces of acne, rosacea, and hidradenitis suppurativa. Clin Dermatol. 2017;35 (2):114-7.10.1016/j.clindermatol.2016.10.00228274347
  45. 45. Ünal E, Güvendi Akçınar U, Arduç A. Hidradenitis Suppurativa, Metabolic Syndrome, and Demodex spp. Infestation. Turkiye Parazitol Derg. 2018; 42(2):171-4.
  46. 46. Tang Q, Li X, Song P, Xu L. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future. Drug Discov Ther. 2015;9(6):380-5.10.5582/ddt.2015.0120726781921
  47. 47. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International. Circulation. 2009;120(16):1640-5.10.1161/CIRCULATIONAHA.109.19264419805654
  48. 48. Brož J, Malinovská J, Nunes MA, Kučera K, Rožeková K, Žejglicová K, et al. Prevalence of diabetes and prediabetes and its risk factors in adults aged 25–64 in the Czech Republic: A cross-sectional study. Diabetes Res Clin Pract 2020; 170:108470.10.1016/j.diabres.2020.10847032998019
  49. 49. Chen YH, Lee YC, Tsao YC, Lu MC, Chuang HH, Yeh WC, et al. Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: A community-based study in Taiwan. BMJ Open. 2018;8(5):1-7.10.1136/bmjopen-2017-016554594246829724734
Language: English
Page range: 47 - 57
Submitted on: Aug 27, 2021
Accepted on: May 11, 2022
Published on: Jul 13, 2022
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2022 Evgeni T. Hristozov, Katya G. Peeva, Valeri N. Malev, Ivelina А. Yordanova, Grisha S. Mateev, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.